MDxHealth's Q3 revenues have significantly exceeded the estimated $17.11M, reaching $19.3M. This represents a 73% increase year-over-year and a 15% increase sequentially. This positive financial performance is likely to boost investor confidence and could lead to a short-term increase in the company's stock price.